Literature DB >> 12205116

Genetic counselling for familial breast and ovarian cancer in Ontario.

A Andermann, S A Narod.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12205116      PMCID： PMC1735233          DOI： 10.1136/jmg.39.9.695

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  4 in total

1.  Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.

Authors:  Marcelo A Carvalho; Sylvia M Marsillac; Rachel Karchin; Siranoush Manoukian; Scott Grist; Ramona F Swaby; Turan P Urmenyi; Edson Rondinelli; Rosane Silva; Luis Gayol; Lisa Baumbach; Rebecca Sutphen; Jennifer L Pickard-Brzosowicz; Katherine L Nathanson; Andrej Sali; David Goldgar; Fergus J Couch; Paolo Radice; Alvaro N A Monteiro
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

2.  Risk for Patient Harm in Canadian Genetic Counseling Practice: It's Time to Consider Regulation.

Authors:  Andrea L Shugar; Nada Quercia; Christopher Trevors; Marina M Rabideau; Sohnee Ahmed
Journal:  J Genet Couns       Date:  2016-06-07       Impact factor: 2.537

Review 3.  BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis.

Authors:  William D Foulkes
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

Review 4.  Germline Missense Variants in BRCA1: New Trends and Challenges for Clinical Annotation.

Authors:  Volha A Golubeva; Thales C Nepomuceno; Alvaro N A Monteiro
Journal:  Cancers (Basel)       Date:  2019-04-12       Impact factor: 6.639
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.